Previous 10 | Next 10 |
AUSTIN, Texas, June 23, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the appointments of two seasoned Board members: Dr. Robert Auerbach and Ms. Ruby ...
AUSTIN, Texas, June 16, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the online publication of a paper validating its OvaWatch™ algorithm ...
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16 th - 20 th , 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Spring in...
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that management will participate in the “MicroCap Rodeo Spring Into Action Best Ideas” Conference virtually and...
Aspira Women's Health, Inc. (AWH) Q1 2022 Earnings Conference Call May 11, 2022, 08:30 ET Company Participants Nicole Sandford - President, Chief Executive Officer and Director Robert Beechey - Chief Financial Officer Michael Newton - Head, Commercial Conference Call Participants Brian Weinst...
Aspira Women’s Health press release (NASDAQ:AWH): Q1 GAAP EPS of -$0.08 in-line. Revenue of $1.89M (+26.8% Y/Y) misses by $0.07M. For further details see: Aspira Women’s Health GAAP EPS of -$0.08 in-line, revenue of $1.89M misses by $0.07M
Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, May 11 ...
AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the first quarter ended March 31, 2022 before the market open on We...
Shares of Aspira Women's Health Inc. (NASDAQ:AWH) traded today at $54.46, eclipsing its 52-week high. This new high was reached on above average trading volume as 32 million shares traded hands, while the average 30-day volume is approximately 429,000 shares. Aspira Womens Health Inc is ...
Shares of Aspira Women's Health Inc. (NASDAQ:AWH) traded today at $54.46, eclipsing its 52-week high. So far today approximately 31.9 million shares have been exchanged, as compared to an average 30-day volume of 433,000 shares. In the past 52 weeks, shares of Aspira Women's Health Inc. ...
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
Aspira Women's Health Inc. Website:
Preliminary OvaWatch ® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuite SM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Heal...
AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that i...
AUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has...